Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
IPV + fIPV + Rotarix
- Development stage
- Unknown
- Modality
- Vaccines & Immunotherapeutics
- Administration
- Intramuscular, Intradermal, Oral
01
Overview
This is a combination vaccination regimen that includes inactivated poliovirus vaccine (IPV), fractional dose inactivated poliovirus vaccine (fIPV), and Rotarix (rotavirus vaccine). IPV is administered by injection in the leg or arm to protect against poliomyelitis caused by poliovirus types 1, 2, and 3. fIPV is a one-fifth (0.1 ml) dose of IPV administered intradermally, which has been shown to offer higher immunogenicity compared to one full intramuscular dose of IPV. Rotarix is an oral rotavirus vaccine administered in two doses at ages 6 and 10 weeks to protect against rotavirus gastroenteritis.
- Brand names
- RotarixIPOLImovax Polio
- Other names
- inactivated poliovirus vaccine + fractional inactivated poliovirus vaccine + RotarixIPV + fIPV + Rotarixpoliomyelitis vaccine (inactivated) + fractional poliomyelitis vaccine (inactivated) + rotavirus vaccine, live, oral
02
Targets
RVA (Rotavirus A)
Beyond the preview
Go deeper on IPV + fIPV + Rotarix.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on IPV + fIPV + Rotarix.